Liver tumor treatment with chemotherapy plus heat ablation surgery
Part of Cancer, Digestive system clinical trials.
This trial tests a combination approach for pancreatic cancer that has spread to a limited number of liver spots. It uses chemotherapy along with a “heat ablation” procedure (guided by ultrasound) to treat liver tumors, aiming to control the cancer more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- Your pancreatic cancer has been confirmed by pathology (biopsy/tissue testing)
- Your liver function is Child-Pugh A or B (milder or moderate liver impairment)
- You can do the study procedures, and your overall function score is high (Karnofsky 80 or more)
- Your liver metastases are limited: either one spot up to 5 cm, or up to 3 spots each up to 3 cm
- Your blood counts and clotting tests are adequate (including platelets above 40,000 and specific clotting ratios)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of treatments for people with advanced pancreatic cancer that has spread to the liver or lungs. It includes a cancer vaccine, two chemotherapy drugs, an immunotherapy drug, and a heat-based therapy to see if it can help shrink tumors and improve outcomes.
This trial tests a combination of endoscopic ultrasound-guided heat ablation (RFA) and the immunotherapy drug pembrolizumab for people with locally advanced or metastatic pancreatic cancer that cannot be surgically removed. The goal is to see if this approach can shrink tumors and improve outcomes.
This trial tests a new combination treatment that uses heat (ablation) and other therapies to destroy liver tumors. It's for people who cannot have surgery or choose not to, and whose tumor is a specific size.
This study tests a new treatment combining tumor destruction with heat/cold (ablation) and an immunotherapy drug (PD-1) for people whose pancreatic cancer has spread to the liver. The goal is to help the immune system fight the cancer better.
This trial tests a heat-based treatment for liver cancer tumors that uses multiple methods to destroy cancer cells. It may help people with liver tumors that haven't spread and who are healthy enough for treatment.
This trial is testing a combination of treatments for liver cancer that cannot be removed by surgery. It combines a targeted therapy pill (lenvatinib), an immunotherapy that boosts your immune system (PD-1 blocker), a procedure that destroys tumors with heat or cold (ablation), and a chemo procedure that delivers medicine directly to the liver (TACE). The goal is to see if this mix is safe and effective.
Hear when a new Pancreatic Ductal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.